I 22
Pill imprint I 22 has been identified as Glycopyrrolate 2 mg.
Glycopyrrolate is used in the treatment of anesthesia; excessive salivation; peptic ulcer and belongs to the drug class anticholinergics/antispasmodics. There is no proven risk in humans during pregnancy.
Glycopyrrolate 2 mg is not subject to the Controlled Substances Act.
See also related documents.
Glycopyrrolate Images
- Imprint:
-
I 22
- Strength:
- 2 mg
- Color:
- White
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Inactive Ingredients:
- lactose monohydrate
magnesium stearate
povidone
calcium phosphate dibasic anhydrous
sodium starch glycolate type A potato
- Drug Class:
- Anticholinergics/antispasmodics
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Dr. Reddy’s Laboratories Inc.
- National Drug Code (NDC):
- 55111-0649
More Glycopyrrolate resources
- Glycopyrrolate (Wolters Kluwer)
- Glycopyrrolate Solution (Wolters Kluwer)
- Glycopyrrolate Tablets (Wolters Kluwer)
- glycopyrrolate (Cerner Multum)
- glycopyrrolate (Micromedex) - Includes Dosage Information
- Glycopyrrolate (AHFS DI)
- Glycopyrrolate Injection (FDA)
- Glycopyrrolate Tablets (FDA)
- Robinul Injection (FDA)
- Glycopyrrolate (Wolters Kluwer)


